Apply to Cambridge Angels

Apply to Cambridge Angels

Oxford Drug Design awarded £1m to progress uUTI treatment

24 Feb

Written By Charlotte Kirby

Charlotte Kirby

Healx doses first subject in Phase II neurofibromatosis type 1 therapy trial

FLIT to ramp up electric bike production as investors pump in £1.2m